Email
Print
Market Overview:
The Flow Diversion Aneurysm Market size is estimated to reach $8.23 billion by 2030, growing at a CAGR of 9% during the forecast period 2024-2030, according to a recent report published by IndustryARC, titled, “Flow Diversion Aneurysm Market Size, Share & Trends Analysis Report - By Device Type (Pipeline Embolization Device (PED), Silk Flow Diverter, Flow Re-direction Endoluminal Device (FRED), p64 Flow-Modulation Device, Surpass Flow-Diverter), By Aneurysm Type (Unruptured, Fusiform, Dissecting, Saccular, Others), By End-User (Hospitals, Specialty Clinics), By Geography – Global Opportunity Analysis & Industry Forecast, 2024-2030”
Better patient outcomes and increasing incidence of cerebral aneurysms are fueling the growth of the Flow Diversion Aneurysm industry during the forecast period.
North America Dominated the Market in 2023:
North America is the largest market for flow diversion technology, holding a significant segmental market share of approximately 35% in 2023. This dominance is attributed to the presence of major manufacturers like Medtronic and Stryker, who have established a strong foothold in the region. Their continuous investment in research and development has led to advancements in flow diversion technology, enhancing treatment efficacy and patient outcomes. Additionally, government initiatives aimed at improving healthcare infrastructure have further supported market growth. Case studies from renowned institutions, such as the Mayo Clinic, demonstrate the successful implementation of these technologies in treating complex intracranial aneurysms.
Flow Diversion Aneurysm Market: Key Takeaways
Better Patient Outcomes is Driving the Market Growth:
The demand for flow diversion aneurysm treatment is rapidly increasing, driven by its effectiveness in improving patient outcomes through the reconstruction of diseased parent vessels and minimizing rupture risks. This minimally invasive procedure redirects blood flow from aneurysms, leading to faster and more reliable occlusion. The technique's growing acceptance in clinical practice is supported by technological advancements and new devices that enhance safety and efficacy. As hospitals and neurosurgeons recognize the superior performance of flow diversion in managing complex aneurysms, this trend reflects a broader shift towards advanced medical interventions prioritizing patient safety and long-term health benefits.
For More Queries About "Flow Diversion Aneurysm Market " @ https://www.industryarc.com/pdfdownload.php?id=509407
Market Growth Driven by Increasing Incidence of Cerebral Aneurysms:
The rising prevalence of cerebral aneurysms significantly drives the flow diversion aneurysm market. An estimated 6.8 million individuals in the U.S. suffer from unruptured brain aneurysms, with approximately 30,000 cases of ruptures occurring annually14. As awareness about these conditions increases, more patients seek effective treatment options, leading to heightened demand for flow diverters. The aging population, which is more susceptible to neurovascular disorders, further exacerbates this trend. Consequently, healthcare providers are increasingly adopting flow diversion techniques as a reliable solution for managing complex aneurysms, propelling market growth.
Scope of the Report:
Recent Developments:
• In June 2022, Medtronic launched the Pipeline Vantage with Shield Technology, a fourth-generation flow diverter for treating brain aneurysms in India. This device features enhanced delivery and implant design, promoting cell growth in blood vessels. Medtronic also introduced a unique warranty program to assure patients of device efficacy, aiming to advance aneurysm therapy and improve patient outcomes.
Flow Diversion Aneurysm Market: Competitive Landscape
Key companies profiled in the Flow Diversion Aneurysm Market are Acandis GmbH, Balt Extrusion, InspireMD, Medtronic plc, Terumo Corporation (MicroVention, Inc.), Phenox GmbH, Stryker Corporation, Endologix LLC, Evasc Medical Systems, Siemens Healthineers, and others.
About IndustryARC™:
IndustryARC primarily focuses on Market Research and Consulting Services specific to Cutting Edge Technologies and Newer Application segments of the market. The company’s Custom Research Services are designed to provide insights into the constant flux in the global demand-supply gap of markets.
IndustryARC’s goal is to provide the right information required by the stakeholder at the right point in time, in a format that assists an intelligent and informed decision-making process.
Contact Us:
Mr. Venkat Reddy
IndustryARC
Email: [email protected]
USA: (+1) 518-282-4727